Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Dementias Invite Scientists to Apply for FTD Grant Award Program

NEW YORK, NY--(Marketwire - June 03, 2008) - The Alzheimer's Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Dementias (AFTD) invite scientists from the biotechnology industry and academia worldwide to apply for research grants through the Frontotemporal Dementia Drug Discovery Program. The goal of the program is to catalyze and fund the discovery and development of effective therapies for frontotemporal dementia (FTD).